company background image
HTL logo

Hamilton Thorne TSX:HTL Stock Report

Last Price

CA$1.30

Market Cap

CA$197.4m

7D

0%

1Y

-18.8%

Updated

28 Mar, 2024

Data

Company Financials +

HTL Stock Overview

Hamilton Thorne Ltd. develops, manufactures, and sells precision instruments, consumables, software, and services for the assisted reproductive technologies (ART), research, and cell biology markets.

HTL fundamental analysis
Snowflake Score
Valuation5/6
Future Growth4/6
Past Performance0/6
Financial Health3/6
Dividends0/6

Hamilton Thorne Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Hamilton Thorne
Historical stock prices
Current Share PriceCA$1.30
52 Week HighCA$1.71
52 Week LowCA$1.05
Beta0.32
1 Month Change-0.76%
3 Month Change-2.26%
1 Year Change-18.75%
3 Year Change-25.71%
5 Year Change18.18%
Change since IPO242.11%

Recent News & Updates

Recent updates

These 4 Measures Indicate That Hamilton Thorne (CVE:HTL) Is Using Debt Reasonably Well

Aug 15
These 4 Measures Indicate That Hamilton Thorne (CVE:HTL) Is Using Debt Reasonably Well

At CA$1.40, Is Hamilton Thorne Ltd. (CVE:HTL) Worth Looking At Closely?

May 25
At CA$1.40, Is Hamilton Thorne Ltd. (CVE:HTL) Worth Looking At Closely?

Is Hamilton Thorne (CVE:HTL) Using Too Much Debt?

Mar 30
Is Hamilton Thorne (CVE:HTL) Using Too Much Debt?

These 4 Measures Indicate That Hamilton Thorne (CVE:HTL) Is Using Debt Safely

Oct 05
These 4 Measures Indicate That Hamilton Thorne (CVE:HTL) Is Using Debt Safely

Should You Think About Buying Hamilton Thorne Ltd. (CVE:HTL) Now?

Jun 10
Should You Think About Buying Hamilton Thorne Ltd. (CVE:HTL) Now?

Hamilton Thorne (CVE:HTL) Will Be Hoping To Turn Its Returns On Capital Around

May 15
Hamilton Thorne (CVE:HTL) Will Be Hoping To Turn Its Returns On Capital Around

Is Hamilton Thorne (CVE:HTL) A Risky Investment?

Apr 12
Is Hamilton Thorne (CVE:HTL) A Risky Investment?

Estimating The Fair Value Of Hamilton Thorne Ltd. (CVE:HTL)

Mar 15
Estimating The Fair Value Of Hamilton Thorne Ltd. (CVE:HTL)

When Should You Buy Hamilton Thorne Ltd. (CVE:HTL)?

Mar 01
When Should You Buy Hamilton Thorne Ltd. (CVE:HTL)?

Has Hamilton Thorne (CVE:HTL) Got What It Takes To Become A Multi-Bagger?

Feb 01
Has Hamilton Thorne (CVE:HTL) Got What It Takes To Become A Multi-Bagger?

Announcing: Hamilton Thorne (CVE:HTL) Stock Soared An Exciting 590% In The Last Five Years

Jan 19
Announcing: Hamilton Thorne (CVE:HTL) Stock Soared An Exciting 590% In The Last Five Years

Are Insiders Selling Hamilton Thorne Ltd. (CVE:HTL) Stock?

Jan 06
Are Insiders Selling Hamilton Thorne Ltd. (CVE:HTL) Stock?

What Did Hamilton Thorne's (CVE:HTL) CEO Take Home Last Year?

Dec 24
What Did Hamilton Thorne's (CVE:HTL) CEO Take Home Last Year?

We Think Hamilton Thorne (CVE:HTL) Can Stay On Top Of Its Debt

Dec 12
We Think Hamilton Thorne (CVE:HTL) Can Stay On Top Of Its Debt

Is It Time To Consider Buying Hamilton Thorne Ltd. (CVE:HTL)?

Nov 30
Is It Time To Consider Buying Hamilton Thorne Ltd. (CVE:HTL)?

A Look At The Fair Value Of Hamilton Thorne Ltd. (CVE:HTL)

Nov 17
A Look At The Fair Value Of Hamilton Thorne Ltd. (CVE:HTL)

Here's Why Hamilton Thorne (CVE:HTL) Can Manage Its Debt Responsibly

Aug 24
Here's Why Hamilton Thorne (CVE:HTL) Can Manage Its Debt Responsibly

Is Now An Opportune Moment To Examine Hamilton Thorne Ltd. (CVE:HTL)?

Aug 10
Is Now An Opportune Moment To Examine Hamilton Thorne Ltd. (CVE:HTL)?

At CA$1.43, Is Hamilton Thorne Ltd. (CVE:HTL) Worth Looking At Closely?

Aug 10
At CA$1.43, Is Hamilton Thorne Ltd. (CVE:HTL) Worth Looking At Closely?

A Look At The Intrinsic Value Of Hamilton Thorne Ltd. (CVE:HTL)

Jul 27
A Look At The Intrinsic Value Of Hamilton Thorne Ltd. (CVE:HTL)

The Hamilton Thorne (CVE:HTL) Share Price Is Up 263% And Shareholders Are Boasting About It

Jul 13
The Hamilton Thorne (CVE:HTL) Share Price Is Up 263% And Shareholders Are Boasting About It

Shareholder Returns

HTLCA Medical EquipmentCA Market
7D0%-2.8%0.4%
1Y-18.8%-20.7%9.0%

Return vs Industry: HTL exceeded the Canadian Medical Equipment industry which returned -20.7% over the past year.

Return vs Market: HTL underperformed the Canadian Market which returned 9% over the past year.

Price Volatility

Is HTL's price volatile compared to industry and market?
HTL volatility
HTL Average Weekly Movement5.2%
Medical Equipment Industry Average Movement11.9%
Market Average Movement8.5%
10% most volatile stocks in CA Market18.4%
10% least volatile stocks in CA Market3.1%

Stable Share Price: HTL has not had significant price volatility in the past 3 months.

Volatility Over Time: HTL's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/an/aKate Torchilinhttps://www.hamiltonthorne.ltd

Hamilton Thorne Ltd. develops, manufactures, and sells precision instruments, consumables, software, and services for the assisted reproductive technologies (ART), research, and cell biology markets. It offers precision laser systems, imaging systems, and other equipment and consumables for the ART and developmental biology research markets. The company also provides test laboratory and endotoxin testing services, as well as sperm assays, including Sperm Motility Index and Sperm Penetration; and fresh and cryopreserved mouse embryos supply, and technician training and proficiency testing services.

Hamilton Thorne Ltd. Fundamentals Summary

How do Hamilton Thorne's earnings and revenue compare to its market cap?
HTL fundamental statistics
Market capCA$197.42m
Earnings (TTM)-CA$822.16k
Revenue (TTM)CA$91.05m

2.2x

P/S Ratio

-240.1x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
HTL income statement (TTM)
RevenueUS$67.23m
Cost of RevenueUS$33.37m
Gross ProfitUS$33.85m
Other ExpensesUS$34.46m
Earnings-US$607.02k

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.004
Gross Margin50.35%
Net Profit Margin-0.90%
Debt/Equity Ratio33.4%

How did HTL perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.